104 related articles for article (PubMed ID: 19684287)
1. A new simple cell-based homogeneous time-resolved fluorescence QRET technique for receptor-ligand interaction screening.
Härmä H; Rozwandowicz-Jansen A; Martikkala E; Frang H; Hemmilä I; Sahlberg N; Fey V; Perälä M; Hänninen P
J Biomol Screen; 2009 Sep; 14(8):936-43. PubMed ID: 19684287
[TBL] [Abstract][Full Text] [Related]
2. Comparison of homogeneous single-label fluorometric binding assays: fluorescence polarization and dual-parametric quenching resonance energy transfer technique.
Härmä H; Sarrail G; Kirjavainen J; Martikkala E; Hemmilä I; Hänninen P
Anal Chem; 2010 Feb; 82(3):892-7. PubMed ID: 20047278
[TBL] [Abstract][Full Text] [Related]
3. A homogeneous single-label time-resolved fluorescence cAMP assay.
Martikkala E; Rozwandowicz-Jansen A; Hänninen P; Petäjä-Repo U; Härmä H
J Biomol Screen; 2011 Mar; 16(3):356-62. PubMed ID: 21343601
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric homogeneous method for identification of ligand binding to G protein-coupled receptors: receptor-ligand binding and β-arrestin assay.
Kopra K; Kainulainen M; Mikkonen P; Rozwandowicz-Jansen A; Hänninen P; Härmä H
Anal Chem; 2013 Feb; 85(4):2276-81. PubMed ID: 23330639
[TBL] [Abstract][Full Text] [Related]
5. Cell-based beta2-adrenergic receptor-ligand binding assay using synthesized europium-labeled ligands and time-resolved fluorescence.
Martikkala E; Lehmusto M; Lilja M; Rozwandowicz-Jansen A; Lunden J; Tomohiro T; Hänninen P; Petäjä-Repo U; Härmä H
Anal Biochem; 2009 Sep; 392(2):103-9. PubMed ID: 19464246
[TBL] [Abstract][Full Text] [Related]
6. A homogeneous single-label quenching resonance energy transfer assay for a δ-opioid receptor-ligand using intact cells.
Kopra K; Shweta ; Martikkala E; Hänninen P; Petäjä-Repo U; Härmä H
Analyst; 2013 Sep; 138(17):4907-14. PubMed ID: 23800721
[TBL] [Abstract][Full Text] [Related]
7. Homogeneous GTP binding assay employing QRET technology.
Rozwandowicz-Jansen A; Laurila J; Martikkala E; Frang H; Hemmilä I; Scheinin M; Hänninen P; Härmä H
J Biomol Screen; 2010 Mar; 15(3):261-7. PubMed ID: 20103692
[TBL] [Abstract][Full Text] [Related]
8. Bioluminescence resonance energy transfer as a screening assay: Focus on partial and inverse agonism.
Elster L; Elling C; Heding A
J Biomol Screen; 2007 Feb; 12(1):41-9. PubMed ID: 17114329
[TBL] [Abstract][Full Text] [Related]
9. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
10. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
Sawutz DG; Sylvestre D; Homcy CJ
J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
[TBL] [Abstract][Full Text] [Related]
11. Single-label time-resolved luminescence assay for estrogen receptor--ligand binding.
Huttunen R; Shweta ; Martikkala E; Lahdenranta M; Virta P; Hänninen P; Härmä H
Anal Biochem; 2011 Aug; 415(1):27-31. PubMed ID: 21477578
[TBL] [Abstract][Full Text] [Related]
12. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
13. Homogeneous single-label biochemical Ras activation assay using time-resolved luminescence.
Martikkala E; Veltel S; Kirjavainen J; Rozwandowicz-Jansen A; Lamminmäki U; Hänninen P; Härmä H
Anal Chem; 2011 Dec; 83(24):9230-3. PubMed ID: 22098697
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence ratiometric detection of ligand-induced receptor internalization using extracellular coiled-coil tag-probe labeling.
Yano Y; Matsuzaki K
FEBS Lett; 2011 Jul; 585(14):2385-8. PubMed ID: 21708150
[TBL] [Abstract][Full Text] [Related]
15. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
Marsh JD; Smith TW
Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
[TBL] [Abstract][Full Text] [Related]
16. Chiral separations of some beta-adrenergic agonists and antagonists on AmyCoat column by HPLC.
Ali I; Saleem K; Gaitonde VD; Aboul-Enein HY; Hussain I
Chirality; 2010 Jan; 22(1):24-8. PubMed ID: 19208401
[TBL] [Abstract][Full Text] [Related]
17. Using the protein chip to screen agonists and antagonists of the androgen receptor.
Zhou Y; Liu A; Wang W; Du G
J Biomol Screen; 2008 Apr; 13(4):276-84. PubMed ID: 18349422
[TBL] [Abstract][Full Text] [Related]
18. A dual-step fluorescence resonance energy transfer-based quenching assay for screening of caspase-3 inhibitors.
Valanne A; Malmi P; Appelblom H; Niemelä P; Soukka T
Anal Biochem; 2008 Apr; 375(1):71-81. PubMed ID: 18211811
[TBL] [Abstract][Full Text] [Related]
19. Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology.
Maurel D; Kniazeff J; Mathis G; Trinquet E; Pin JP; Ansanay H
Anal Biochem; 2004 Jun; 329(2):253-62. PubMed ID: 15158484
[TBL] [Abstract][Full Text] [Related]
20. Homogeneous TR-FRET high-throughput screening assay for calcium-dependent multimerization of sorcin.
Appelblom H; Nurmi J; Soukka T; Pasternack M; Penttilä KE; Lövgren T; Niemelä P
J Biomol Screen; 2007 Sep; 12(6):842-8. PubMed ID: 17579123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
